fluorescein-5-isothiocyanate has been researched along with icatibant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, XP; Oda, D; Pakhlevaniants, S; Rubinstein, I | 1 |
| Hickey, MJ; Lew, RA; Norman, MU; Smith, AI | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and icatibant
| Article | Year |
|---|---|
Smokeless tobacco-exposed oral keratinocytes increase macromolecular efflux from the in situ oral mucosa.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Cells, Cultured; Cheek; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Humans; Keratinocytes; Kinetics; Leupeptins; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Plants, Toxic; Tobacco, Smokeless | 1998 |
Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature.
Topics: Animals; Bradykinin; Bradykinin Receptor Antagonists; Capillary Permeability; Cerebral Veins; Cerebrovascular Circulation; Dextrans; Dose-Response Relationship, Drug; Fluorescein-5-isothiocyanate; Male; Metalloendopeptidases; Microcirculation; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2 | 2003 |